FdaApplication

NDA 021107

Back to search

Identifiers

Properties

PropertyValue
applicant_nameLEGACY PHARMA INC SEZC
application_typeNDA
approval_date2000-02-09

Products (2)

ProductActive ingredientStrengthDosage form
LOTRONEXALOSETRON HYDROCHLORIDEEQ 1MG BASETABLET;ORAL
LOTRONEXALOSETRON HYDROCHLORIDEEQ 0.5MG BASETABLET;ORAL

2 products